companydata.dkcompanydata.dk

GSK 2023 ApS: Financial statements 2025

CVR: 43456415

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

GSK 2023 ApS (CVR 43456415) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -30,332 and a net result of DKK -5,937 compared with DKK 372,677 the year before. Equity in the 2025 report amounted to DKK 4,181,703. The solvency ratio was 86.8%.

Gross Profit
DKK -30,332
Profit/Loss
DKK -5,937
Equity
DKK 4,181,703
Total Assets
DKK 4,819,576
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--30K-6K4.2M0
2024--34K373K4.2M0
2023--593K3.5M3.8M1
2022--570K23M91.2M1
2021--341K10.1M85.6M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is GSK 2023 ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

GSK 2023 ApS: The 2024 annual report is outMay 6, 2025

GSK 2023 ApS has published its annual report for 2024. Gross profit came to DKK -33,520, and the net result was DKK 372,677.

About GSK 2023 ApS

GSK 2023 ApS is a Danish company of the type Anpartsselskab based in Sæby, founded in 1972. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named B6 HOLDING A/S and B 6 AF 1972 A/S. The management consists of Brian Stenbro. The board consists of Kurt Valdemar Stenbro (chair), Brian Stenbro and Malene Stenbro. The company is owned by M.A.S.T. Holding ApS, BriSt Holding 2023 ApS and KVS Holding, Sæby ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -30,332 and a net result of DKK -5,937 compared with DKK 372,677 the year before. Equity in the 2025 report amounted to DKK 4,181,703.

Source: annual report 2025, Danish Business Authority